当前位置: X-MOL 学术Nat. Commun. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Nature Communications ( IF 14.7 ) Pub Date : 2020-09-23 , DOI: 10.1038/s41467-020-18767-0
Xiao Gao 1, 2, 3 , Qingwei Wang 4 , Ying Wang 5 , Jiang Liu 5 , Shuang Liu 6 , Jian Liu 7 , Xingli Zhou 3 , Li Zhou 3 , Hui Chen 3 , Linian Pan 3 , Jiwei Chen 3 , Da Wang 1, 2 , Qing Zhang 6 , Shihui Shen 3 , Yu Xiao 3 , Zhipeng Wu 1, 2 , Yiyun Cheng 3 , Geng Chen 3 , Syeda Kubra 3 , Jun Qin 8 , Lan Huang 9 , Pei Zhang 10 , Chuangui Wang 11 , Robb E Moses 12 , David M Lonard 12 , Bert W O' Malley 12 , Fuad Fares 13 , Bianhong Zhang 3 , Xiaotao Li 1, 12 , Lei Li 3 , Jianru Xiao 1, 2
Affiliation  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

中文翻译:

作者更正:REGγ 抑制剂 NIP30 增加了 p53 缺陷肿瘤细胞对化疗的敏感性。

对本文的修订已发布,可通过本文顶部的链接访问。
更新日期:2020-09-23
down
wechat
bug